
Radiofrequency ablation for adenoma in patients with primary aldosteronism and hypertension: ADERADHTA, a pilot study
Author(s) -
Béatrice Bouhanick,
Marie-Charlotte Delchier,
Séverine Lagarde,
Romain Boulestreau,
C Conil,
Philippe Gosse,
Hervé Rousseau,
Benoît Lepage,
Pascale Olivier,
Panteleimon Papadopoulos,
Hervé Trillaud,
Antoine Crémer
Publication year - 2020
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/hjh.0000000000002708
Subject(s) - medicine , primary aldosteronism , secondary hypertension , aldosterone , adrenal adenoma , hyperaldosteronism , clinical endpoint , blood pressure , adenoma , radiofrequency ablation , ambulatory , urology , ambulatory blood pressure , cardiology , ablation , clinical trial
To evaluate the efficacy and the feasibility of radiofrequency ablation to treat aldosterone-producing adenomas.